CUX1
Basic information
Region (hg38): 7:101815904-102283958
Previous symbols: [ "CUTL1" ]
Links
Phenotypes
GenCC
Source:
- global developmental delay with or without impaired intellectual development (Definitive), mode of inheritance: AD
- global developmental delay with or without impaired intellectual development (Strong), mode of inheritance: AD
- autosomal dominant non-syndromic intellectual disability (Supportive), mode of inheritance: AD
- global developmental delay with or without impaired intellectual development (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Global developmental delay with or without impaired intellectual development | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 30014507 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (206 variants)
- Inborn_genetic_diseases (153 variants)
- Global_developmental_delay_with_or_without_impaired_intellectual_development (89 variants)
- CUX1-related_disorder (30 variants)
- not_specified (17 variants)
- Duane_retraction_syndrome (3 variants)
- Neurodevelopmental_disorder (2 variants)
- See_cases (2 variants)
- Myeloproliferative_neoplasm (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CUX1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000181552.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 48 | 6 | 55 | ||
| missense | 2 | 287 | 36 | 1 | 326 | |
| nonsense | 13 | 11 | 4 | 28 | ||
| start loss | 0 | |||||
| frameshift | 4 | 13 | 7 | 24 | ||
| splice donor/acceptor (+/-2bp) | 1 | 4 | 10 | 15 | ||
| Total | 18 | 30 | 309 | 84 | 7 |
Highest pathogenic variant AF is 0.000006571511
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| CUX1 | protein_coding | protein_coding | ENST00000360264 | 24 | 468291 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125737 | 0 | 11 | 125748 | 0.0000437 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 3.75 | 543 | 851 | 0.638 | 0.0000572 | 9753 |
| Missense in Polyphen | 4 | 20.007 | 0.19993 | 283 | ||
| Synonymous | -0.541 | 396 | 383 | 1.04 | 0.0000285 | 3009 |
| Loss of Function | 7.25 | 6 | 72.7 | 0.0825 | 0.00000367 | 824 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000905 | 0.0000904 |
| Ashkenazi Jewish | 0.000103 | 0.0000992 |
| East Asian | 0.000163 | 0.000109 |
| Finnish | 0.0000472 | 0.0000462 |
| European (Non-Finnish) | 0.0000443 | 0.0000439 |
| Middle Eastern | 0.000163 | 0.000109 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in intra-Golgi retrograde transport. {ECO:0000269|PubMed:15718469}.;
- Pathway
- Disease;Vesicle-mediated transport;Membrane Trafficking;Intra-Golgi traffic;Signaling by FGFR in disease;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Signaling by FGFR1 in disease;Diseases of signal transduction;Intra-Golgi and retrograde Golgi-to-ER traffic
(Consensus)
Recessive Scores
- pRec
- 0.449
Intolerance Scores
- loftool
- 0.407
- rvis_EVS
- -1.87
- rvis_percentile_EVS
- 2.01
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.783
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;retrograde transport, vesicle recycling within Golgi;regulation of transcription by RNA polymerase II;multicellular organism development;peptidyl-tyrosine phosphorylation;Golgi vesicle transport;positive regulation of dendrite morphogenesis
- Cellular component
- Golgi membrane;nucleus;nucleoplasm;Golgi apparatus;cytosol
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;protein tyrosine kinase activity;protein binding, bridging;sequence-specific DNA binding